Thiosulfate Sulfurtransferase 5 (SSEA-5) Antikörper

Produktnummer ABIN7469616

Dieser Maus Monoklonal Antikörper detektiert spezifisch Thiosulfate Sulfurtransferase 5 in FACS, ICC, IF und IHC. Es zeigt Reaktivität gegenüber Proben von Human.

Kurzübersicht für Thiosulfate Sulfurtransferase 5 (SSEA-5) Antikörper (ABIN7469616)

Target: Thiosulfate Sulfurtransferase 5 (SSEA-5)

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Unkonjugiert

Applikation: Flow Cytometry (FACS), Immunocytochemistry (ICC), Immunofluorescence (IF), Immunohistochemistry (IHC)

Klon: 8-00E-11

Produktdetails

Kreuzreaktivität: Human

Aufreinigung: Protein G affinity purified

Immunogen: Undifferentiated human embryonic stem cells

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: ICC/IF: 1:50-1:1000. FACS: 1:50. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 mg/mL

Buffer: PBS, No Preservative

Konservierungsmittel: Without preservative

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.

Antigendetails

Target: Thiosulfate Sulfurtransferase 5 (SSEA-5)

Andere Bezeichnung: SSEA-5

Hintergrund:

Synonyms: Stage-Specific Embryonic Antigen-5 , SSEA-5

Background: Stage-specific embryonic antigen (SSEA)-5 is an H type-1 glycan that is highly and specifically expressed on human embryonic stem cells (hESCs), the human blastocyst inner cell mass and undifferentiated human pluripotent stem cells (hPSCs). Expression of SSEA-5 in hESCs and hPSCs rapidly decreases upon differentiation and is considered an indicator of undifferentiated PSCs. This SSEA-5 antibody is capable of identifying undifferentiated pluripotent stem cells in heterogeneous populations, and when used in conjunction with other pluripotency surface markers (CD9 and CD90 or CD50 and CD200), it can be used to immunodeplete residual teratoma-causing cells from incompletely differentiated embryonic stem cell cultures.